# Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy

> **NCT01332253** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 161 (actual)

## Conditions studied

- Tonsillectomy

## Interventions

- **DRUG:** Intravenous ibuprofen
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT01332253
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332253, "Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01332253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*